drugset / Trial / NCT01020994
Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to determine the efficacy and safety of topical application of LAS41003 in comparison to LAS189962 and LAS189961 in the treatment of superinfected eczema.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAS41003 | Unknown | — | Topical |
| Comparator | Octenidine | Small molecule | — | Topical |
| Comparator | Prednicarbate | Small molecule | — | Topical |